SCHEMBL23745621

SCHEMBL23745621

CCCCCCC(C)(CC)CCc1c[nH]cn1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19521895 1.00 KCNH2 (0.30) KCNH2
SCHEMBL21982584 0.83 CNR2 (0.33)
SCHEMBL23085646 0.82 CNR2 (0.32)
SCHEMBL31554343 0.79 KCNH2 (0.47) KCNH2
SCHEMBL2695561 0.79 KCNH2 (0.47) KCNH2
SCHEMBL28061446 0.79 KCNH2 (0.47) KCNH2
SCHEMBL674217 0.79 KCNH2 (0.47) KCNH2
SCHEMBL2697514 0.79 KCNH2 (0.47) KCNH2
SCHEMBL2697904 0.79 KCNH2 (0.47) KCNH2
SCHEMBL25751850 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210246115-A1 ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF BIOIMICS AB (SE) 2021-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210246115-A1 ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF FDPS, FPR1, F12 KCNH2 1865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.